2013

von Bonin, M., Wermke, M., Cosgun, K.N., Thiede, C., Bornhauser, M., Wagemaker, G. & Waskow, C. (2013) In vivo expansion of co-transplanted T cells impacts on tumor re-initiating activity of human acute myeloid leukemia in NSG mice. PLoS One, 8, e60680.

Thol, F., Suchanek, K.J., Koenecke, C., Stadler, M., Platzbecker, U., Thiede, C., Schroeder, T., Kobbe, G., Kade, S., Loffeld, P., Banihosseini, S., Bug, G., Ottmann, O., Hofmann, W.K., Krauter, J., Kroger, N., Ganser, A. & Heuser, M. (2013) SETBP1 mutation analysis in 944 patients with MDS and AML. Leukemia, 27, 2072-2075.

Stolzel, F., Platzbecker, U., Mohr, B., Rollig, C., Middeke, J.M., Thiede, C., Fussel, M., Hanel, M., Schaich, M., Ehninger, G., Schetelig, J. & Bornhauser, M. (2013) Early intervention with allogeneic hematopoietic cell transplantation during chemotherapy-induced aplasia in patients with high-risk acute myeloid leukemia. Leukemia, 27, 2068-2072.

Shayegi, N., Kramer, M., Bornhauser, M., Schaich, M., Schetelig, J., Platzbecker, U., Rollig, C., Heiderich, C., Landt, O., Ehninger, G. & Thiede, C. (2013) The level of residual disease based on mutant NPM1 is an independent prognostic factor for relapse and survival in AML. Blood, 122, 83-92.

Serve, H., Krug, U., Wagner, R., Sauerland, M.C., Heinecke, A., Brunnberg, U., Schaich, M., Ottmann, O., Duyster, J., Wandt, H., Fischer, T., Giagounidis, A., Neubauer, A., Reichle, A., Aulitzky, W., Noppeney, R., Blau, I., Kunzmann, V., Stuhlmann, R., Kramer, A., Kreuzer, K.A., Brandts, C., Steffen, B., Thiede, C., Muller-Tidow, C., Ehninger, G. & Berdel, W.E. (2013) Sorafenib in combination with intensive chemotherapy in elderly patients with acute myeloid leukemia: results from a randomized, placebo-controlled trial. J Clin Oncol, 31, 3110-3118.

Schonefeldt, C., Sockel, K., Wehner, R., Sopper, S., Wolf, D., Wermke, M., Thiede, C., Oelschlagel, U., Ehninger, G., Bornhauser, M., Platzbecker, U. & Schmitz, M. (2013) Azacytidine impairs NK cell activity in AML and MDS patients undergoing MRD-based pre-emptive treatment after allogeneic stem cell transplantation. Blood Cancer J, 3, e136.

Schaich, M., Parmentier, S., Kramer, M., Illmer, T., Stolzel, F., Rollig, C., Thiede, C., Hanel, M., Schafer-Eckart, K., Aulitzky, W., Einsele, H., Ho, A.D., Serve, H., Berdel, W.E., Mayer, J., Schmitz, N., Krause, S.W., Neubauer, A., Baldus, C.D., Schetelig, J., Bornhauser, M. & Ehninger, G. (2013) High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial. J Clin Oncol, 31, 2094-2102.

Ortlepp, C., Steudel, C., Heiderich, C., Koch, S., Jacobi, A., Ryser, M., Brenner, S., Bornhauser, M., Brors, B., Hofmann, W.K., Ehninger, G. & Thiede, C. (2013) Autotaxin is expressed in FLT3-ITD positive acute myeloid leukemia and hematopoietic stem cells and promotes cell migration and proliferation. Exp Hematol, 41, 444-461 e444.

Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S.M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., Specchia, G., Sica, S., Divona, M., Levis, A., Fiedler, W., Cerqui, E., Breccia, M., Fioritoni, G., Salih, H.R., Cazzola, M., Melillo, L., Carella, A.M., Brandts, C.H., Morra, E., von Lilienfeld-Toal, M., Hertenstein, B., Wattad, M., Lubbert, M., Hanel, M., Schmitz, N., Link, H., Kropp, M.G., Rambaldi, A., La Nasa, G., Luppi, M., Ciceri, F., Finizio, O., Venditti, A., Fabbiano, F., Dohner, K., Sauer, M., Ganser, A., Amadori, S., Mandelli, F., Dohner, H., Ehninger, G., Schlenk, R.F., Platzbecker, U., Gruppo Italiano Malattie Ematologiche, d.A., German-Austrian Acute Myeloid Leukemia Study, G. & Study Alliance, L. (2013) Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. N Engl J Med, 369, 111-121.

Link, C.S., Platzbecker, U., Kroschinsky, F., Pannach, S., Thiede, C., Platzek, I., Ehninger, G. & Schuler, M.K. (2013) Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis. Case Rep Oncol, 6, 311-315.

Lenk, J., Bornhauser, M., Kramer, M., Holig, K., Poppe-Thiede, K., Schmidt, H., Wiesneth, M., Schaefer-Eckart, K., Schlenke, P., Punzel, M., Martin, S., Kroschinsky, F., Schmidt, A.H., Ehninger, G. & Thiede, C. (2013) Sex and body mass index but not CXCL12 801 G/A polymorphism determine the efficacy of hematopoietic cell mobilization: a study in healthy volunteer donors. Biol Blood Marrow Transplant, 19, 1517-1521.